ZE150612 — Uther Tirzepatide
Vendor COAUther | Tirzepatide, last activity 1 month ago
Vendor certificate from Janoshik shows 99.84% purity; first seen one to three months ago.
5 related batch concerns · 3 mentions · summary from 4 sources · updated Sep 20
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 15 mg. Janoshik weighed 17.8 mg — 19% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
17 units
on a U-100 insulin syringe, for 1.5 mg
Going by the label you would draw 20 units — which from this vial is actually 1.78 mg, not 1.5 mg.
- The vial holds dry powder: 17.8 mg of Tirzepatide, as weighed.
- Water spreads that powder evenly through the liquid: 17.8 mg ÷ 2 ml = 8.91 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 89 mcg.
- Your dose divided by that: 1.5 mg ÷ 89 mcg = 17 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
This batch is getting unusual attention for its age, with one positive report and one test request in recent discussion
also Uther
A community group test is forming with seven participants
PT-141, same vendor
One concern was raised about this batch
GYC/GGpeps
Endotoxin levels have exceeded the 10 EU/vial working limit in two independent Janoshik tests (17.116 and 47.923…
also Uther
Vendor's own certificate shows 99.9% purity
Community Intelligence
- 2 concern reports involving ZE100701
- 1 concern report involving PT10-0528
- 2 concern reports involving PT10-0617
- 1 concern report involving 2026061030
- 2 concern reports involving SN26XY-1-02
Reported against other Uther Tirzepatide batches, not this one.
Also known as: T150612T15-0612
Activity
🌍 UTHER 2026 SUMMER Around the World 🚨 JUST RELEASED 🚨 🔥 NEW ACTIVITY BATCHES Third-Party Tested • Limited Stock • While Supplies Last ⸻ ⭐ SS-31 100 mg | Batch: SS100-0401 💲 350 USD 🔗 [h...
View in Telegram →members only𝕯𝖆𝖛𝖊: [https://verify.janoshik.com/tests/198431-Tir_15mg_ZE150612_HZ77QK88DPVE](https://verify.janoshik.com/tests/198431-Tir_15mg_ZE150612_HZ77QK88DPVE)
View in Telegram →members only𝕯𝖆𝖛𝖊: https://verify.janoshik.com/tests/198431-Tir_15mg_ZE150612_HZ77QK88DPVE
View in Telegram →members onlyVendor
Uther